eli lilly glp-1 drug FDA approves Foundayo, an oral alternative to Wegovy and Ozempic Lilly's three-pronged drug puts obesity

But theres good news: medications like Semaglutide and Tirzepatide are changing the game for women with PCOS

Ania Jastreboff, MD, PhD , can be reached at [email protected]

Unimolecular peptides with dual GIP/GLP-1 receptor agonism have been developed to improve metabolic efficacy and therapeutic index beyond what incretin mono-agonists can achieve (44, 63)

Weight loss may reduce levothyroxine requirements in some individuals, though this is not universal

The notion that you can go off it in six months this so-called quick-start approach, I got this, doc, just get me started and I'll take it from there is not really how obesity is treated